BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30066907)

  • 1. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
    Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
    Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.
    Gao S; Zhu L; Feng H; Hu Z; Jin S; Song Z; Liu D; Liu J; Hao Y; Li X; Lin B
    Tumour Biol; 2016 Sep; 37(9):12251-12262. PubMed ID: 27240592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer.
    Hao Y; Zhu L; Yan L; Liu J; Liu D; Gao N; Tan M; Gao S; Lin B
    Oncol Rep; 2017 Dec; 38(6):3355-3366. PubMed ID: 29130097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Lewis y antigen on regulating gene expression of partial drug resistance associated proteins in human ovarian cancer cell line RMG-I-H].
    Liu Q; Lin B; Wang PL; Yan LM; Hao YY; Li FF; Zhu LC; Zhang SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Aug; 31(4):481-7. PubMed ID: 19771739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun transcriptionally regulates alpha 1, 2-fucosyltransferase 1 (FUT1) in ovarian cancer.
    Gao N; Liu J; Liu D; Hao Y; Yan L; Ma Y; Zhuang H; Hu Z; Gao J; Yang Z; Shi H; Lin B
    Biochimie; 2014 Dec; 107 Pt B():286-92. PubMed ID: 25239830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and ANXA4/NF‑κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma.
    Liu J; Wang H; Zheng M; Deng L; Zhang X; Lin B
    Int J Mol Med; 2020 Dec; 46(6):2102-2114. PubMed ID: 33125094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha1,2-fucosyl transferase gene, the key enzyme of Lewis y synthesis, promotes Taxol resistance of ovarian carcinoma through apoptosis-related proteins.
    Li FF; Sha D; Qin XY; Li CZ; Lin B
    Neoplasma; 2018; 65(4):515-522. PubMed ID: 29940750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway.
    Liu JJ; Lin B; Hao YY; Li FF; Liu DW; Qi Y; Zhu LC; Zhang SL; Iwamori M
    Oncol Rep; 2010 Mar; 23(3):833-41. PubMed ID: 20127027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.
    Yan L; Wang C; Lin B; Liu J; Liu D; Hou R; Wang Y; Gao L; Zhang S; Iwamori M
    Biochimie; 2015 Jun; 113():17-25. PubMed ID: 25726913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.
    Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M
    J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells.
    Zhuang H; Hu Z; Tan M; Zhu L; Liu J; Liu D; Yan L; Lin B
    Biochimie; 2014 Oct; 105():91-8. PubMed ID: 24998328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them.
    Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B
    Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effect of anti-Lewis y antibody on alpha1,2-fucosyltransferase gene transfected human ovarian cancer cells in vitro].
    Li FF; Lin B; Hao YY; Liu JJ; Zhang F; Zhang SL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):267-9. PubMed ID: 18328190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A4 fucosylation enhances its interaction with the NF-kB p50 and promotes tumor progression of ovarian clear cell carcinoma.
    Wang H; Deng L; Cai M; Zhuang H; Zhu L; Hao Y; Gao J; Liu J; Li X; Lin B
    Oncotarget; 2017 Dec; 8(64):108093-108107. PubMed ID: 29296226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma.
    Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells.
    Hu Z; Cai M; Deng L; Zhu L; Gao J; Tan M; Liu J; Lin B
    Oncotarget; 2016 Dec; 7(50):82921-82932. PubMed ID: 27863372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
    Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
    Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Lewis Y antigen on the gene expression of multiple drug resistance-associated proteins in human ovarian cancer RMG-I-H cells.
    Gao S; Liu Q; Wang X; Lin B; Zhang S
    Med Oncol; 2010 Sep; 27(3):960-7. PubMed ID: 19771531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
    Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
    Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.